Press release
Major Force in the Self-Administered Parenteral Market 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion
Self Administered Parenteral Market
The self-administered parenteral market has experienced strong growth in recent years. It will rise from $24.57 billion in 2024 to $26.04 billion in 2025, at a CAGR of 6.0%. This growth is driven by the rise in chronic diseases, the aging population, government initiatives, patient education and support programs, and the increasing incidences of bone disorders.
The self-administered parenteral market is expected to grow steadily, reaching $31.18 billion by 2029, at a CAGR of 4.6%. This growth is attributed to an increasing preference for home healthcare, the rise of telemedicine and remote monitoring, patient education, and the growing personalized medicine sector. Trends include the integration of digital health solutions, customized drug delivery systems, emerging targeted therapies, and advancements in biologics.
What Key Elements Are Boosting Growth in the Self-Administered Parenteral Market?
The rising prevalence of chronic diseases is expected to propel the growth of the self-administered parenteral market. Chronic diseases are long-term medical conditions that develop gradually and require ongoing treatment and management. Self-administered parenteral therapies enable patients to manage their treatment independently, improving medication adherence compared to oral drugs. For instance, in January 2023, the National Institutes of Health, a U.S. government agency, projected that among individuals aged 50 and older, the number of people with at least one chronic illness would surge by 99.5%, increasing from 71.52 million in 2020 to 142.66 million by 2050. Thus, the increasing burden of chronic diseases is driving the growth of the self-administered parenteral market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp
Who Are the Major Industry Players Fueling Self-Administered Parenteral Market Expansion?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG
Which Key Developments Are Influencing the Self-Administered Parenteral Market?
Companies in the self-administered parenteral market are developing innovative products like the UDENYCA autoinjector to improve patient accessibility and treatment options. For example, in May 2023, Coherus BioSciences Inc., a US-based biotech firm, launched the UDENYCA autoinjector in the US. This self-administered, single-dose, prefilled autoinjector offers patients a convenient option for pegfilgrastim delivery, featuring an intuitive push-on-skin activation mechanism for fast and reliable administration.
How Is the Segmentation of the Self-Administered Parenteral Market Defined?
The self-administered parenteral market covered in this report is segmented -
1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications
Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report
What Is the Leading Region in the Self-Administered Parenteral Market?
North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Self-Administered Parenteral Global Market Report?
- Market Size Analysis: Analyze the Self-Administered Parenteral Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Self-Administered Parenteral Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Self-Administered Parenteral Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Self-Administered Parenteral Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Force in the Self-Administered Parenteral Market 2025: Chronic Diseases Fueling Self-Administered Parenteral Market Expansion here
News-ID: 3854108 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Administered
Leading Element Driving Change in the Self-Administered Parenteral Market in 202 …
"What combination of drivers is leading to accelerated growth in the self-administered parenteral market?
The increasing prevalence of chronic illnesses is anticipated to drive the expansion of the self-administered parenteral market. Chronic diseases are enduring health conditions that typically develop gradually and frequently necessitate continuous care and treatment. Self-administered parenteral products play a pivotal role in managing chronic conditions, allowing individuals to control their treatments, which can result in increased adherence…
Self-Administered Drugs Market Global Rising Demand & Huge Scope Till 2032
The global self-administered drugs market was valued at approximately USD 95.53 billion in 2023 and is projected to reach USD 204.08 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2032.
Self-Administered Drugs Market Overview
The self-administered drugs market is experiencing significant growth, primarily driven by the increasing prevalence of chronic diseases such as diabetes, asthma, and osteoporosis. Patients are seeking convenient and effective…
Self-administered Drugs Market 2023 Trends with Analysis on Key Players
Drugs that are administered by patients themselves are known as self-administered drugs. These drugs can be taken through implantable and non-implantable infusion pumps that come in contact with the skin surface. OTC, Oral and Topical preparations are also considered self-administered drugs. Active lifestyles have prompted patients to seek drugs that would not only save time, but would enable them to avoid hospitals altogether (except in emergency cases).
Self-administered Drugs Market research…
Self-Administered Medication Market to Register Substantial Expansion by 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
This Market Research report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Request for a sample of this research report @ https://www.xploremr.com/connectus/sample/1929
Scope
The…
Self-Administered Medication Market Progresses for Huge Profits During 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
This Market Research report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Download Sample Copy of this report @ https://www.xploremr.com/connectus/sample/1929
Scope
The scope of…
Self-Administered Medication Market to Register Unwavering Growth During 2026
Growing prevalence of various chronic diseases is expected to fuel demand for the self-administered medication globally. In addition, increasing collaboration among manufacturers is expected to impact growth of the global market significantly.
Report overview @ https://www.xploremr.com/report/1929/self-administered-medication-market
This Fact.MR report analyzes the expansion of global self-administered medication market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.
Scope
The scope of Fact.MR’s report is to analyze…
